Eris Lifesciences Limited (ERIS.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3620
First IPO Date
June 30, 2017
| Name | Title | Pay | Year Born |
| Inderjeet Singh Negi | Executive Director | 12.4M | 1971 |
| Kaushal Kamlesh Shah | Whole Time Director | 16.82M | 1979 |
| Krishnakumar Vaidyanathan | Executive Director & Chief Operating Officer | 45.78M | 1975 |
| Amit Indubhushan Bakshi | Chairman & MD | 48.78M | 1975 |
| Deepak Kapoor | Senior Vice President | 0 | 1964 |
| Gagan Atreja | President of Sales & Marketing | 0 | 1969 |
| Milind Talegaonkar | Compliance Officer & Company Secretary | 0 | N/A |
| Murari Ranganathan | President of Cardiometabolic Business | 0 | N/A |
| Sachin Shah | Chief Financial Officer | 0 | 1980 |
| Vijay S. Joshi | President of Medical | 0 | 1953 |
Eris Lifesciences Limited is an Indian pharmaceutical company engaged in the manufacturing, marketing, and distribution of medicinal products throughout the country. The company provides a comprehensive range of branded formulations, catering to a wide spectrum of therapeutic areas. These encompass cardiovascular health, anti-diabetic treatments, anti-infectives, antipyretics, vitamin/nutrient supplements, gastroenterology, respiratory care, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, alongside services in in-vitro fertilization, cosmetology, and dermatology. Founded in 2007, Eris Lifesciences Limited is headquartered in Ahmedabad, India.